View, browse and sort the list of CPhI North America Conference sessions and show floor programming by pass type, track, and format. Seating is first come, first serve, so please arrive early to sessions that you would like to attend. Sessions are subject to change.

[Improving Solubility Spotlight] Hot Melt Extrusion Challenges and Solutions- Part II - AbbVie Hot Melt Extrusion Capabilities


Anna VanDyke (Senior Sales Manager, AbbVie)

Location: 119A

Date: Tuesday, April 24

Time: 3:55pm - 4:15pm

Pass Type: Conference Pass, VIP Attendee - Get your pass now!

Track: Drug Development

Vault Recording: TBD

AbbVie has successfully developed, scaled-up and commercialized many challenging chemical entities using proprietary hot melt extrusion technology. Hot melt extrusion (HME) is a proven technology for bioavailability enhancement of poorly soluble API's. Unlike other formulation options, hot melt extrusion technology is solvent-free. By drawing on continuous processing, hot melt extrusion is more economical and can be used for abuse deference and taste masking applications. This can ultimately deliver a higher quality, more marketable pharmaceutical product.